Cas No.: | 205923-56-4 |
pH value: | Corresponds to reference standard: PASS |
Non-reduced CE-SDS: | 98.7% |
SEC-HPLC: | 99.5% |
Isoelectric Point: | Corresponds to reference standard:PASS |
Bacterial Endotoxins Test: | <1 EU/ml |
Exogenous Residual DNA: | <1 pg/mg |
Residual protein A: | <1 ng/mg |
Biological Activity: | Compared with standard, the range of biological activity is 102% |
Osmolality: | Corresponds to reference standard: PASS |
Peptide mapping: | Corresponds to reference standard: PASS |
N-terminal sequence: | Corresponds to reference standard:PASS |
Description: | Cetuximab, a novel molecular-targeted agent,is an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation. |